An expert speaks at a meeting on the adjustment of the national medical insurance reimbursement list in Beijing, capital of China, Oct. 18, 2020. China has included 119 more kinds of drugs in its national medical insurance reimbursement list, delivering greater price cuts and benefiting more people, the National Healthcare Security Administration (NHSA) said at a press conference Monday. Ninety-six of the new additions to the list are exclusive drugs that offer lower prices through negotiation and 16 were newly put on the market this year, the NHSA said. (Xinhua/Zhang Yuwei)